C3 신염의 병리 = Pathology of C3 Glomerulonephritis

다국어 초록 (Multilingual Abstract)

C3 glomerulonephritis (C3GN) is a recently described entity that shows a glomerulonephritis on light microscopy, bright C3 staining and the absence of C1q, C4, and immunoglobulins on immunofluorescence microscopy and mesangial and/or subendothelial electron-dense deposits on electron microscopy. The term 'C3 glomerulopathy' is often used to include C3GN and dense deposit disease (DDD), CFHR5 nephropathy, those of which result from dysregulation of the alternative pathway of complement. C3GN shares some aspects of atypical hemolytic uremic syndrome, MPGN, late stage of post infectious glomerulonephritis and other glomerulonephrtis. When C3GN is considered, measurement of serum complement proteins including C3, CFH, CFI, CFB and testing for the presence of C3 nephritic factor, anti-factor H autoantibodies are necessary. To screening for mutations, genes that encode complement regulators should be evaluated. This disorder equally affected all ages, both genders, and typically presented with hematuria and proteinuria. In both the short and long term, renal function remained stable in the majority of patients.

참고문헌 (Reference)

1 de Córdoba SR, "Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H" 151 : 1-13, 2008

2 Pickering MC, "Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains" 204 : 1249-1256, 2007

3 Sethi S, "Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement" 6 : 1009-1017, 2011

4 Servais A, "Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome" 44 : 193-199, 2007

5 Appel GB, "Membranoproliferative glomerulonephritis type II (dense deposit disease): an update" 16 : 1392-1403, 2005

6 Sethi S, "Membranoproliferative glomerulone-phritis-a new look at an old entity" 366 : 1119-1131, 2012

7 Sethi S, "Membranoproliferative glome- rulonephritis and C3 glomerulopathy: resolving the confusion" 81 : 434-441, 2012

8 Licht C, "Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis" 101 : 271-278, 2009

9 Sethi S, "Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway" 75 : 952-960, 2009

10 Bomback AS, "Eculizumab for dense deposit disease and C3 glomerulonephritis" 7 : 748-756, 2012

11 Fakhouri F, "C3 glomerulopathy: a new classification" 6 : 494-499, 2010

12 Sethi S, "C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up" 82 : 465-473, 2012

13 Sethi S, "C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up" 82 : 465-473, 2012

14 Servais A, "Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies" 82 : 454-464, 2012